AKT1 and non-small cell lung carcinoma: In NSCLC Aloe-emodin may increase PC9-GR cells’ sensitivity to gefitinib and reverse epithelial–mesenchymal transition (EMT) via inhibiting the PI3K/Akt/TWIS1 signal pathway [292].